SCHEMBL735447

SCHEMBL735447

c1ccc2c(CCn3cccn3)c[nH]c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.56
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 2/20 0.54
NPC1 O15118 1/20 0.54
GAA P10253 1/20 0.54
RAB9A P51151 1/20 0.54
CYP3A4 P08684 2/20 0.53
HTR6 P50406 2/20 0.53
HTR2C P28335 2/20 0.53
MPO P05164 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2A6 P11509 1/20 0.53
NFKB1 P19838 1/20 0.53
HTR1D P28221 1/20 0.53
HTR1B P28222 1/20 0.53
HTR7 P34969 1/20 0.53
CTSK P43235 1/20 0.53
CYP2A13 Q16696 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14110600 0.84 HTR2A (0.55) HTR2AMEN1KMT2AMAPTNPC1
SCHEMBL29188240 0.82 HTR2A (0.64) HTR2AMEN1KMT2AMAPTNPC1
SCHEMBL735019 0.82 MPO (0.59) HTR2AKMT2AMPOHTR1AGPR84
SCHEMBL29788835 0.81 HTR2A (0.55) HTR2AMEN1KMT2AMAPTNPC1
SCHEMBL735834 0.79 HTR2A (0.54) HTR2AMEN1KMT2AMAPTNPC1
SCHEMBL12479624 0.77 MAPT (0.52) HTR2AMEN1KMT2AMAPTNPC1
SCHEMBL15336440 0.77 MEN1 (0.52) HTR2AMEN1KMT2AMAPTNPC1
SCHEMBL734128 0.77 TBXAS1 (0.74) HTR2AMEN1KMT2AMAPTNPC1
SCHEMBL4985934 0.76 HTR2A (0.77) HTR2AMEN1KMT2AMAPTCYP3A4
Hydrochloric Acid SCHEMBL408332 0.75 TBXAS1 (0.72) HTR2AMEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101516844-B 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH 2013-12-11 CN disclosed
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
CN-101516844-A 4-heteroaryl substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having activity on opioid receptor systems GRUENENTHAL GMBH (DE) 2009-08-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 HTR2A 238/4885MEN1 2253/4885KMT2A 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.